Skip to main content
eScholarship
Open Access Publications from the University of California

Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort.

  • Author(s): Balagopal, Ashwin
  • Gupte, Nikhil
  • Shivakoti, Rupak
  • Cox, Andrea L
  • Yang, Wei-Teng
  • Berendes, Sima
  • Mwelase, Noluthando
  • Kanyama, Cecilia
  • Pillay, Sandy
  • Samaneka, Wadzanai
  • Santos, Breno
  • Poongulali, Selvamuthu
  • Tripathy, Srikanth
  • Riviere, Cynthia
  • Lama, Javier R
  • Cardoso, Sandra W
  • Sugandhavesa, Patcharaphan
  • Semba, Richard D
  • Hakim, James
  • Hosseinipour, Mina C
  • Kumarasamy, Nagalingeswaran
  • Sanne, Ian
  • Asmuth, David
  • Campbell, Thomas
  • Bollinger, Robert C
  • Gupta, Amita
  • et al.
Abstract

Background.  We assessed immune activation after antiretroviral therapy (ART) initiation to understand clinical failure in diverse settings. Methods.  We performed a case-control study in ACTG Prospective Evaluation of Antiretrovirals in Resource-Limited Settings (PEARLS). Cases were defined as incident World Health Organization Stage 3 or 4 human immunodeficiency virus (HIV) disease or death, analyzed from ART weeks 24 (ART24) to 96. Controls were randomly selected. Interleukin (IL)-6, interferon (IFN)-γ-inducible protein-10, IL-18, tumor necrosis factor-α, IFN-γ, and soluble CD14 (sCD14) were measured pre-ART and at ART24 in plasma. Continued elevation was defined by thresholds set by highest pre-ART quartiles (>Q3). Incident risk ratios (IRRs) for clinical progression were estimated by Poisson regression, adjusting for age, sex, treatment, country, time-updated CD4+ T-cell count, HIV ribonucleic acid (RNA), and prevalent tuberculosis. Results.  Among 99 cases and 234 controls, median baseline CD4+ T-cell count was 181 cells/µL, and HIV RNA was 5.05 log10 cp/mL. Clinical failure was independently associated with continued elevations of IL-18 (IRR, 3.03; 95% confidence interval [CI], 1.27-7.20), sCD14 (IRR, 2.17; 95% CI, 1.02-4.62), and IFN-γ (IRR, 0.08; 95% CI, 0.01-0.61). Among 276 of 333 (83%) who were virologically suppressed at ART24, IFN-γ was associated with protection from failure, but the association with sCD14 was attenuated. Conclusions.  Continued IL-18 and sCD14 elevations were associated with clinical ART failure. Interferon-γ levels may reflect preserved immune function.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
Current View